Encouraging results of blood conservation in neonatal open-heart surgery

J Thorac Cardiovasc Surg. 2024 Mar;167(3):1154-1163. doi: 10.1016/j.jtcvs.2023.07.032. Epub 2023 Jul 29.

Abstract

Objective: To report early outcomes of blood conservation in neonatal open-heart surgery.

Methods: Ninety-nine patients undergoing neonatal open-heart surgery during the implementation of a blood conservation program between May 2021 and February 2023 were reviewed. Patients either received traditional blood management (blood prime, n = 43) or received blood conservation strategies (clear prime, n = 56). Baseline characteristics and outcomes were compared between groups.

Results: There was no difference in body weight (median, 3.2 kg vs 3.3 kg; P = .83), age at surgery (median, 5 days vs 5 days; P = .37), distribution of The Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery Congenital Heart Surgery Mortality Categories categories or duration of cardiopulmonary bypass. Patients in the clear prime group had higher preoperative hematocrit (median, 41% vs 38%; P < .01), shorter postoperative mechanical ventilation time (median, 48 hours vs 92 hours; P = .02) and postoperative intensive care unit length of stay (median, 6 days vs 9 days; P < .01) than patients in the blood prime group. Fourteen patients (25%) in the clear prime group, including 1 Norwood patient, were discharged without any transfusion. Among patients within the clear prime group, hospitalizations without blood exposure were associated with higher preoperative hematocrit (median, 43% vs 40%; P = .02), shorter postoperative mechanical ventilation times (median, 22 hours vs 66 hours; P = .01) and shorter postoperative hospital stays (median, 10 days vs 15 days; P = .02).

Conclusions: Bloodless surgery is possible in a significant proportion of neonates undergoing open-heart surgery, including the Norwood operation, even in the early stages of experience. Early clinical results are favorable but long-term follow-up and continued efforts are warranted to prove safety and reproducibility.

Keywords: blood conservation; bloodless surgery; cardiopulmonary bypass; neonates.

MeSH terms

  • Blood Transfusion / methods
  • Cardiac Surgical Procedures* / adverse effects
  • Cardiopulmonary Bypass / methods
  • Heart Defects, Congenital* / surgery
  • Humans
  • Infant, Newborn
  • Length of Stay
  • Reproducibility of Results
  • Retrospective Studies
  • Treatment Outcome